# Biodesix Inc: Form 8-K, filed Nov 21, 2022

- Company: [Biodesix Inc](/companies/bdsx.md) (CIK 1439725)
- Form: 8-K
- Filed: 2022-11-21
- Accepted by EDGAR: Nov 21, 2022, 16:05 ET
- Period: 2022-11-16
- Accession: 0000950170-22-025530
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/bdsx-20221116.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/bdsx-20221116.htm

Filed Nov 21, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-025530. Last ingested by Listed: Nov 12, 2026, 19:59 ET. No prices; not investment advice.